Cited 79 times in
COVID-19 in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최준용 | - |
dc.date.accessioned | 2020-09-30T16:44:48Z | - |
dc.date.available | 2020-09-30T16:44:48Z | - |
dc.date.issued | 2020-07 | - |
dc.identifier.issn | 0032-5473 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/179605 | - |
dc.description.abstract | A novel coronavirus (severe acute respiratory syndrome-CoV-2) that initially originated from Wuhan, China, in December 2019 has already caused a pandemic. While this novel coronavirus disease (COVID-19) frequently induces mild diseases, it has also generated severe diseases among certain populations, including older-aged individuals with underlying diseases, such as cardiovascular disease and diabetes. As of 31 March 2020, a total of 9786 confirmed cases with COVID-19 have been reported in South Korea. South Korea has the highest diagnostic rate for COVID-19, which has been the major contributor in overcoming this outbreak. We are trying to reduce the reproduction number of COVID-19 to less than one and eventually succeed in controlling this outbreak using methods such as contact tracing, quarantine, testing, isolation, social distancing and school closure. This report aimed to describe the current situation of COVID-19 in South Korea and our response to this outbreak. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | BMJ Publishing Group | - |
dc.relation.isPartOf | POSTGRADUATE MEDICAL JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Basic Reproduction Number | - |
dc.subject.MESH | Betacoronavirus / pathogenicity* | - |
dc.subject.MESH | Communicable Disease Control / organization & administration* | - |
dc.subject.MESH | Coronavirus Infections / epidemiology* | - |
dc.subject.MESH | Coronavirus Infections / prevention & control | - |
dc.subject.MESH | Coronavirus Infections / transmission* | - |
dc.subject.MESH | Epidemiological Monitoring | - |
dc.subject.MESH | Evidence-Based Medicine | - |
dc.subject.MESH | Human Activities / statistics & numerical data* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Pandemics / prevention & control* | - |
dc.subject.MESH | Pneumonia, Viral / epidemiology* | - |
dc.subject.MESH | Pneumonia, Viral / prevention & control | - |
dc.subject.MESH | Pneumonia, Viral / transmission* | - |
dc.subject.MESH | Quarantine / organization & administration* | - |
dc.subject.MESH | Republic of Korea / epidemiology | - |
dc.subject.MESH | Social Distance | - |
dc.subject.MESH | Travel | - |
dc.title | COVID-19 in South Korea | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Jun Yong Choi | - |
dc.identifier.doi | 10.1136/postgradmedj-2020-137738 | - |
dc.contributor.localId | A04191 | - |
dc.relation.journalcode | J03892 | - |
dc.identifier.eissn | 1469-0756 | - |
dc.identifier.pmid | 32366457 | - |
dc.identifier.url | https://pmj.bmj.com/content/96/1137/399.long | - |
dc.contributor.alternativeName | Choi, Jun Yong | - |
dc.contributor.affiliatedAuthor | 최준용 | - |
dc.citation.volume | 96 | - |
dc.citation.number | 1137 | - |
dc.citation.startPage | 399 | - |
dc.citation.endPage | 402 | - |
dc.identifier.bibliographicCitation | POSTGRADUATE MEDICAL JOURNAL, Vol.96(1137) : 399-402, 2020-07 | - |
dc.identifier.rimsid | 67176 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.